Tuesday, December 13, 2016

BRIEF-Ab Initio Biotherapeutics announces strategic collaboration with Pfizer to discover GPCR activating antibodies

* Ab Initio - addition of will somers, ph.d., vice president

of biomedicines design at pfizer, to ab initio scientific

advisory board

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)